Pharmaceutical Technology18 小时
MRT-6160 by Monte Rosa Therapeutics for Rheumatoid Arthritis: Likelihood of Approval
MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Rheumatoid Arthritis.